INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,000 | -33.3% | 157 | -8.2% | 0.00% | 0.0% |
| Q1 2022 | $12,000 | -40.0% | 171 | +2.4% | 0.00% | -33.3% |
| Q4 2021 | $20,000 | -4.8% | 167 | +7.7% | 0.00% | -25.0% |
| Q3 2021 | $21,000 | -8.7% | 155 | +8.4% | 0.00% | 0.0% |
| Q2 2021 | $23,000 | +187.5% | 143 | +43.0% | 0.00% | +100.0% |
| Q1 2021 | $8,000 | +60.0% | 100 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $5,000 | +150.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,000 | -99.0% | 100 | -99.4% | 0.00% | -98.9% |
| Q1 2020 | $197,000 | +19.4% | 16,108 | +43.6% | 0.09% | +45.2% |
| Q4 2019 | $165,000 | +587.5% | 11,215 | +647.7% | 0.06% | +520.0% |
| Q2 2019 | $24,000 | -68.0% | 1,500 | -72.7% | 0.01% | -79.6% |
| Q4 2018 | $75,000 | -35.3% | 5,495 | +35.8% | 0.05% | -29.0% |
| Q3 2018 | $116,000 | – | 4,045 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |